SCHEMBL688980

SCHEMBL688980

Cc1cc(O)c(N)c(C)c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
MAPT P10636 4/20 0.61
GAA P10253 4/20 0.61
TSHR P16473 2/20 0.41
CASP1 P29466 1/20 0.41
PDE10A Q9Y233 1/20 0.41
CYP3A4 P08684 3/20 0.40
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
G6PD P11413 1/20 0.40
CYP2C9 P11712 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
CCR6 P51684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL8983366 0.97 ALDH1A1 (0.59) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL17914229 0.84 ALDH1A1 (0.61) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL17914234 0.80 ALDH1A1 (0.56) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL8079519 0.79 ALDH1A1 (0.50) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL2741242 0.79 ALDH1A1 (0.50) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL15778376 0.78 ALDH1A1 (0.55) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL9493725 0.78 ALDH1A1 (0.96) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL28959876 0.77 MAPT (0.48) ALDH1A1MAPTGAATSHRCASP1
Hydrochloric Acid SCHEMBL5901427 0.77 ALDH1A1 (0.54) ALDH1A1MAPTGAATSHRCASP1
SCHEMBL393790 0.75 ACHE (0.50) ALDH1A1MAPTGAATSHRCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1709508-A Use of acetylcholinesterase inhibitor for preparing diabetes medicines SHANGHAI SAIDA BIOTECHNOLOGY R (CN) 2005-12-21 CN claimed
CN-1640399-A Use of acetylchloinesterase inhibitor for preparing medicine for treating parkinson's disease SAIDA BIOLOG TECHNOLOGY RES CT (CN) 2005-07-20 CN claimed
EP-4308668-B1 BASE OIL COMPOSITION, FORMULATION AND USE CARGILL BIOINDUSTRIAL UK LTD (GB) 2026-05-06 EP disclosed
US-12540289-B2 Lubricant composition comprising traction coefficient additive CARGILL BIOINDUSTRIAL UK LIMITED (GB) 2026-02-03 US disclosed
US-20250263620-A1 LUBRICANT COMPOSITION COMPRISING TRACTION COEFFICIENT ADDITIVE CARGILL BIOINDUSTRIAL UK LTD (GB) 2025-08-21 US disclosed
EP-4347752-B1 LUBRICANT COMPOSITION COMPRISING TRACTION COEFFICIENT ADDITIVE CARGILL BIOINDUSTRIAL UK LTD (GB) 2025-04-30 EP disclosed
US-20240376394-A1 LUBRICANT COMPOSITION COMPRISING TRACTION COEFFICIENT ADDITIVE CARGILL BIOINDUSTRIAL UK LIMITED (GB) 2024-11-14 US disclosed
EP-4352187-A1 LUBRICANT COMPOSITION COMPRISING TRACTION COEFFICIENT ADDITIVE Cargill Bioindustrial UK Limited (GB) 2024-04-17 EP disclosed
EP-4308668-A1 BASE OIL COMPOSITION, FORMULATION AND USE Equus UK Topco Ltd (GB) 2024-01-24 EP disclosed
WO-2022258664-A1 LUBRICANT COMPOSITION COMPRISING TRACTION COEFFICIENT ADDITIVE EQUUS UK TOPCO LTD (GB) 2022-12-15 WO disclosed
WO-2022194739-A1 BASE OIL COMPOSITION, FORMULATION AND USE CRODA INTERNATIONAL PLC (GB) 2022-09-22 WO disclosed
EP-1637122-B1 2-(Amino or substituted Amino)-3-5-6-substituted Phenol compounds, dyeing compositions containing them, and use thereof PROCTER & GAMBLE (US) 2012-02-29 EP disclosed
CN-101173036-B Method for producing aquosity cashew shell liquid solidifying agent SHANGHAI CHANGFENG CHEMICAL FACTORY OF SHANGHAI COATINGS CO LTD 2010-04-21 CN disclosed
CN-100431539-C Use of acetylchloinesterase inhibitor for preparing medicine for treating parkinson's disease SAIDA BIOLOG TECHNOLOGY RES CT (CN) 2008-11-12 CN disclosed
CN-101173036-A Method for producing aquosity cashew shell liquid solidifying agent SHANGHAI CHANGFENG CHEMICAL FA (CN) 2008-05-07 CN disclosed
US-7338537-B2 2-(amino or substituted amino)-3-5-6-substituted phenol compounds, dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-03-04 US disclosed
EP-1637122-A1 2-(Amino or substituted Amino)-3-5-6-substituted Phenol compounds, dyeing compositions containing them, and use thereof The Procter & Gamble Company (US) 2006-03-22 EP disclosed
US-20060032000-A1 2-(Amino or substituted amino)-3-5-6-substituted phenol compounds, dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY 2006-02-16 US disclosed
CN-1709508-A Use of acetylcholinesterase inhibitor for preparing diabetes medicines SHANGHAI SAIDA BIOTECHNOLOGY R (CN) 2005-12-21 CN disclosed
CN-1640399-A Use of acetylchloinesterase inhibitor for preparing medicine for treating parkinson's disease SAIDA BIOLOG TECHNOLOGY RES CT (CN) 2005-07-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060032000-A1 2-(Amino or substituted amino)-3-5-6-substituted phenol compounds, dyeing compositions containing them, and use thereof KRT18, S100A6, S100A4 ALDH1A1 459/4885MAPT 361/4885GAA 4385/4885
US-12540289-B2 Lubricant composition comprising traction coefficient additive ITGA2, TLN1, ITGB2 ALDH1A1 3355/4885MAPT 1726/4885GAA 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.